NL-OMON34802已完成4 期
Pharmacokinetics of ertapenem in a three-weekly dosing regime in patients with end stage renal disease depending on hemodialysis - Pharmacokinetics of ertapenem in hemodialysis patients
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Hemodialysis patient
排除标准
- •- Age < 18
- •- Liverdisease
- •- Alcoholabuse
- •- Allergy for carbapenems
- •- Diarrhoea
- •- Use of valproicacid, probenicid
- •- Pregnancy or lactation
研究者
相似试验
进行中（未招募）
不适用
Pharmacokinetics of ertapenem in a three-weekly dosing regime in patients with end stage renal disease depending on hemodialysisInfection (bacterial)EUCTR2010-020492-23-NLSint Franciscus Gasthuis8
进行中（未招募）
不适用
Pharmacokinetics of ertapenem in patients with severe sepsis and intraabdominal infectioSevere sepsis caused by intraabdominal infection either peritonitis or pancreatitisEUCTR2009-015948-42-EEniversity of Tartu, Faculty of Medicine8
已完成
4 期
Ertapenem Pharmacokinetics in Patients in Continuous Ambulatory Peritoneal DialysisContinuous Ambulatory Peritoneal DialysisEnd Stage Renal DiseaseNCT00939952Albany College of Pharmacy and Health Sciences7
已完成
2 期
PHARMACOKINETICS AND PHARMACODYNAMICS OF ERTAPENEM IN PATIENTS WITH TUBERCULOSIS10028440tuberculosisTBNL-OMON43693niversitair Medisch Centrum Groningen12
进行中（未招募）
不适用
BLOOD CONCENTRATION OF ERTAPENEM IN PATIENTS WITH TUBERCULOSISTuberculosisEUCTR2012-003386-18-NLMCG